in CTEPH, and how might emerging data address these needs? - - PowerPoint PPT Presentation

in cteph and how might emerging data address
SMART_READER_LITE
LIVE PREVIEW

in CTEPH, and how might emerging data address these needs? - - PowerPoint PPT Presentation

What is currently the greatest unmet clinical need in CTEPH, and how might emerging data address these needs? Professor Marc Humbert Professor of Respiratory Medicine, Universit Paris-Saclay, Le Kremlin- Bictre, France Disclaimer


slide-1
SLIDE 1

Professor Marc Humbert

Professor of Respiratory Medicine, Université Paris-Saclay, Le Kremlin- Bicêtre, France

What is currently the greatest unmet clinical need in CTEPH, and how might emerging data address these needs?

slide-2
SLIDE 2

Unapproved products or unapproved uses of approved products may be discussed by the faculty; these situations may reflect the approval status in one or more jurisdictions. The presenting faculty have been advised by touchIME to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by touchIME of any unapproved products or unapproved uses is either made or implied by mention of these products

  • r uses in touchIME activities.

touchIME accepts no responsibility for errors or omissions.

Disclaimer

slide-3
SLIDE 3

Cumulative incidence of CTEPH after a first episode of pulmonary embolism in patients without prior DVT

CTEPH, chronic thromboembolic pulmonary hypertension; DVT, deep vein thrombosis. Pengo V, et al. N Engl J Med 2004;350:2257–2264.

0.00 0.01 0.02 0.03 0.04 1 2 3 4 5 6 7 8 9 10 11

Cumulative incidence of CTEPH Years

slide-4
SLIDE 4

Microvascular disease in CTEPH: Bronchial-to-pulmonary venous shunting

CTEPH, chronic thromboembolic pulmonary hypertension. Dorfmuller P, et al. Eur Respir J 2014;44:1275–1288.

Pulmonary artery Thromboembolic material Hypertrophic vasa vasorum Pulmonary vein Hypertrophic bronchial artery Bronchus Hemangiomatosis-like capillary remodeling Pulmonary vein remodeling

slide-5
SLIDE 5

CTEPH treatment algorithm: A multimodal, individualized approach

a. Multidisciplinary: pulmonary endarterectomy surgeon, PH expert, BPA interventionist and radiologist. b. Treatment assessment may differ depending on the level of expertise. c. BPA without medical therapy can be considered in selected cases. BPA, balloon angioplasty; CTEPH, chronic thromboembolic pulmonary hypertension; PH, pulmonary hypertension. Kim NH, et al. Eur Respir J 2019;53:1801915.

CTEPH diagnosis Continue lifelong anticoagulation Treatment assessment by expert CTEPH teama,b Persistent/recurrent symptomatic pulmonary hypertension Operable Non-operable Pulmonary endarterectomy (treatment of choice) Targeted medical therapy with or without BPAb,c